Carta Healthcare is a technology company.
Carta Healthcare has raised $35.0M across 2 funding rounds.
Carta Healthcare has raised $35.0M in total across 2 funding rounds.
Carta Healthcare is a healthcare technology company that builds AI-powered platforms to automate clinical data abstraction, standardization, and analysis. It serves major U.S. health systems like Stanford University Medical Center, CommonSpirit, UCSF, and Mass General Brigham, solving the problem of labor-intensive manual data processes that cause clinician burnout and delay patient care improvements[1][4][7]. The company's Cartographer platform searches, analyzes, and standardizes patient and operational data across systems, powering products like Atlas for registry submissions and Navigator for operational challenges, enabling faster access to 4% of U.S. patients' data for science initiatives[1]. With significant growth since its 2017 founding—including a $20 million Series B round—Carta reduces costs, enhances data quality, and frees clinicians for direct care[1][4].
Founded in 2017 in San Francisco, Carta Healthcare was co-founded by Matt Hollingsworth, who serves as CEO, driven by his recognition of administrative burdens exacerbating clinician shortages and burnout post-pandemic[1]. The idea emerged from the need to transform traditional clinical data abstraction—manual, slow, and error-prone—using a hybrid of AI technology and human expertise to unlock clinical data's value for better patient outcomes[1][2][4]. Early traction came from serving top health systems, reaching 20 leading clients by securing Series B funding amid economic challenges, and expanding its platform to cover vast patient data volumes[1][4].
Carta Healthcare rides the wave of AI in healthcare data management, addressing exploding clinical data volumes amid staffing shortages and regulatory demands for quality reporting[1][5][7]. Timing is ideal post-pandemic, as burnout and manual processes hinder care; Carta's solutions cut abstraction time and costs, enabling data-driven decisions in trials, registries, and operations[1][4][6]. Market forces like value-based care and AI adoption favor it, influencing the ecosystem by partnering with registries (e.g., Fivos, MedAxiom) and investors like UPMC Enterprises to standardize data across specialties like cardiology and vascular[5][6][7].
Carta Healthcare is poised for expansion through deeper AI integration and partnerships, targeting more specialties and health systems amid rising data demands. Trends like real-time analytics and clinician-AI hybrids will accelerate its growth, potentially broadening to global markets or trial matching. Its influence may evolve from abstraction leader to full ecosystem enabler, empowering precise, scalable patient care improvements that started with unlocking clinical data's hidden value[1][5][7].
Carta Healthcare has raised $35.0M in total across 2 funding rounds.
Carta Healthcare's investors include Jamison Hill, Embedded Capital, LocalGlobe, Passion Capital, Storm Ventures, Harsh Sinha, Jan Deepen, Stefan Jeschonnek, Tony Jamous, Victor Jacobsson, Asset Management Ventures, Curie.Bio.
Carta Healthcare has raised $35.0M across 2 funding rounds. Most recently, it raised $18.0M Series B in May 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2025 | $18.0M Series B | Jamison Hill, Embedded Capital, LocalGlobe, Passion Capital, Storm Ventures, Harsh Sinha, Jan Deepen, Stefan Jeschonnek, Tony Jamous, Victor Jacobsson | |
| Apr 1, 2021 | $17.0M Series A | Asset Management Ventures, Jamison Hill, Curie.Bio, Deerfield Management, Embedded Capital, Fifth Wall, Franklin Templeton Investments, General Catalyst, GE Ventures, King River Capital, LocalGlobe, Maverick Capital, Nexus Venture Partners, Operator Partners, Passion Capital, PS Investments, Redpoint Ventures, Rock Health, Storm Ventures, Tiger Global Management, TMV, Town Hall Ventures, True Ventures, Visionaire Ventures, Y Combinator, Alex Tang, Halle Tecco, Harsh Sinha, Jan Deepen, Jeff Hammerbacher, Raj Gollamudi, Stefan Jeschonnek, Tony Jamous, Victor Jacobsson, Vivek Garipalli |